Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J H Sohn

Showing results (81-90 of 84) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 84 results.
Abdominal Imaging|October 26, 2005
Abdominal cavernous Iymphangiomas: CT findingsJ-H Sohn, J H Byun, S H Park, et al.
British Journal of Cancer|August 25, 2012
Brain metastases in Asian HER2-positive breast cancer patients: anti-HER2 treatments and their impact on survivalY S Yap, G H Cornelio, B C R Devi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 30, 2022
Long-term efficacy and safety of addition of carboplatin with or without veliparib to standard neoadjuvant chemotherapy in triple-negative breast cancer: 4-year follow-up data from BrighTNess, a randomized phase III trialC E Geyer, W M Sikov, J Huober, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 22, 2025
Patient-reported outcomes in the SERENA-6 trial of camizestrant plus CDK4/6 inhibitor in patients with advanced breast cancer and emergent ESR1 mutations during first-line endocrine-based therapyE L Mayer, F-C Bidard, Y H Park, et al.
Pageof 9

Showing results (81-90 of 84) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 84 results.
Abdominal Imaging|October 26, 2005
Abdominal cavernous Iymphangiomas: CT findingsJ-H Sohn, J H Byun, S H Park, et al.
British Journal of Cancer|August 25, 2012
Brain metastases in Asian HER2-positive breast cancer patients: anti-HER2 treatments and their impact on survivalY S Yap, G H Cornelio, B C R Devi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 30, 2022
Long-term efficacy and safety of addition of carboplatin with or without veliparib to standard neoadjuvant chemotherapy in triple-negative breast cancer: 4-year follow-up data from BrighTNess, a randomized phase III trialC E Geyer, W M Sikov, J Huober, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 22, 2025
Patient-reported outcomes in the SERENA-6 trial of camizestrant plus CDK4/6 inhibitor in patients with advanced breast cancer and emergent ESR1 mutations during first-line endocrine-based therapyE L Mayer, F-C Bidard, Y H Park, et al.
Pageof 9